In contrast, CLL patients also have increased serum levels of IL-2, IL-12, and IFNα, which stimulate NK cells and may counteract the suppressive effects of other cytokines [21]. The gene discussed is IL2; the disease is B-cell chronic lymphocytic leukemia.